West Pharmaceutical Services’ Post

Two terms that often arise in discussions of pharmaceutical manufacturing and production processes are "sterile" and "clean." While they might seem interchangeable at first glance, understanding their nuanced differences is crucial for maintaining high standards of quality and safety in the pharmaceutical industry. Learn more in our latest blog here: https://lnkd.in/eNNmYTXE

Another webinar in the learning series😀!

New date! Flawless Functionality: Optimizing Injectable Drug Stability and Performance will launch on July 25th at 9am EST. Register for our webinar to gain insight into how pharmaceutical packaging providers consider the functionality of drugs when creating innovative packaging solutions. https://bit.ly/45rEoD3

A QMM rating system will foster a more robust drug supply chain and greater commitment to quality in pharmaceutical manufacturing. Download the whitepaper today to find out where your organization is on the QMM scale. https://bit.ly/3VR5vEr

Follow the link below to learn from RCA's pharmaceutical consultants about CAPA programs and how preventative action aligns with manufacturing drug quality. https://ow.ly/lT8050QrN9x

What should businesses keep an eye on for the U.S. pharmaceutical supply chain industry? In this article, we're sharing takeaways from the June 2024 PDG-FDA DSCSA Meeting and our recommendations for U.S. pharmaceutical supply chain stress testing ahead of the final DSCSA ruling. https://lnkd.in/eh-Z_zNM

The United States Pharmacopeia (USP) chapter 665 marks a significant shift in how single-use systems (SUSs) are regulated in the pharmaceutical manufacturing sector. The final version was published in 2022 and will become mandatory by 2026, giving manufacturers a crucial window to prepare and adapt. Many challenges lie ahead for adopting the new USP 665 guidelines. How is your organization preparing for these changes? https://hubs.li/Q02NFB610 #biopharma

Understanding the four stages of drug development is crucial for the pharmaceutical industry. Learn more and explore the world of drug development here. https://hubs.la/Q02tDSVV0

What should businesses keep an eye on for the U.S. pharmaceutical supply chain industry? In this article, we're sharing takeaways from the June 2024 PDG-FDA DSCSA Meeting and our recommendations for U.S. pharmaceutical supply chain stress testing ahead of the final DSCSA ruling. https://hubs.ly/Q02G7lxv0

File assessment guideline